PATHOGENESIS OF CORONAVIRUS INFECTION COVID-19

Authors

  • V. P. Maly Kharkiv Medical Academy of Postgraduate Education
  • I. M. Asoyan Kharkiv Medical Academy of Postgraduate Education
  • I. V. Sai Municipal Non-profit Enterprise “Kryvy Rih City Hospital No. 7” of Kryvy Rih City Council
  • I. V. Andrusovych Kharkiv Medical Academy of Postgraduate Education

DOI:

https://doi.org/10.11603/1681-2727.2020.3.11555

Keywords:

pathogenesis, pathomorphology, coronavirus infection, SARS-CoV-2, COVID-19

Abstract

Coronavirus SARS-CoV-2, penetrates through the mucous membranes of the respiratory tract and enterocytes of the small intestine through ACE2 receptors. Most ACE2 is expressed on the surface of cells of the respiratory tract, especially on type I and II alveolocytes, which explains the lung damage in infected people. Disruption of the gas exchange process associated with damage to the alveoli and capillaries leads to hypoxemia and secondary (indirect) damage to internal organs and systems. The pathogen SARS-CoV-2, which uses the ACE2 receptor to penetrate cells, is promoted by proteases that are inside these cells. ACE2 activity is due, in particular, IFN, the role and participation of which in the infectious process is being studied. The development of systemic vasculitis due to the tropism of the glycoprotein of coronavirus to endothelial cells that have the ACE receptor also indirectly leads to pathological changes in the lungs, heart, brain, kidneys, gastrointestinal tract. As a result of endothelial dysfunction and programmed necrotic cell death (apoptosis and piroptosis) in COVID-19, there is a systemic violation of microcirculation in the vascular bed of various organs and systems, which characterizes the clinical manifestations and consequences in infected. The autoimmune mechanism of defeat of internals is not excluded also. Binding of SARS-CoV-2 to receptors on the cell surface leads to an inflammatory process with the production of pro-inflammatory cytokines, the concentration of which can be extremely high in the form of the so-called “cytokine storm” that underlies ARDS and MODS. The risk of death is directly associated with high serum IL-6 levels.

After 5-7 days from the onset of the disease there is interstitial pneumonia, initially focal, which quickly turns into drainage. The system of mononuclear phagocytes is affected; lymphopenia develops, IFN synthesis is suppressed. Coronavirus pneumonia can be complicated by the accession of bacterial flora, as evidenced by increased levels of procalcitonin in the serum, it also occurs when the patient’s condition worsens. In addition, the patient’s severity is accompanied by high levels of CRP, LDH, D-dimer, ferritin and the like. At the same time there are changes in the blood coagulation system. The level of hemoglobin decreases, which aggravates the hypoxic syndrome.

Pathomorphological changes of ARDS include acute exudative and productive phases. In the first phase, signs of diffuse alveolar damage, acute bronchiolitis, edema and hemorrhage of interstitial tissue predominate. The productive phase is characterized by the development of fibrosing alveolitis with the organization of exudate in the lumen of the alveoli and bronchioles. coronavirus infection can also cause serious damage to other internal organs and systems.

Thus, pathomorphological changes in infected SARS-CoV-2 are due to the direct action of nCoV, hyperactivity of the immune system, high levels of cytotoxicity of CD8 + T cells, autoimmune processes and the like.

Author Biographies

V. P. Maly, Kharkiv Medical Academy of Postgraduate Education

Professor, MD, Kharkiv Medical Academy of Postgraduate Education, Head of the Department of Infectious Diseases

I. M. Asoyan, Kharkiv Medical Academy of Postgraduate Education

PhD (Medicine), Kharkiv Medical Academy of Postgraduate Education, Associate Professor of the Department of Infectious Diseases

I. V. Sai, Municipal Non-profit Enterprise “Kryvy Rih City Hospital No. 7” of Kryvy Rih City Council

Municipal Non-Commercial Enterprise “Kryvy Rih City Hospital No. 7” of the Kryvy Rih City Council, patho­lo­gist

I. V. Andrusovych, Kharkiv Medical Academy of Postgraduate Education

Kharkiv Medical Academy of Postgraduate Education, postgraduate of the Department of Infectious Diseases

References

Tyrrell, D.A.J., & Bynoe, M.L. (1966). Cultivation of viruses from a high proportion of patients with colds. Lancet, 76-7. DOI: 10.1016/S0140-6736(66)92364-6. DOI: https://doi.org/10.1016/S0140-6736(66)92364-6

Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health, 25 (3), 278. DOI: 10.1111/tmi.13383. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5.

Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol., 38 (1), 1-9. DOI: 10.12932/AP-200220-077.

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., ... & Müller, M. A. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https://doi.org/10.1016/j.cell.2020.02.052. DOI: https://doi.org/10.1016/j.cell.2020.02.052

Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020). Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications. DOI: 10.1016/j.bbrc.2020.03.044. DOI 10.12932/AP-200220-0772. DOI: https://doi.org/10.1016/j.bbrc.2020.03.044

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., ... & Tian, D. S. (2020). Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases. DOI: 10.1093/cid/ciaa248. DOI: https://doi.org/10.1093/cid/ciaa248

Zhang H. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46 (4). 586-590. DOI:10.1007/s00134-020-05985-9.

Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of Medicine, 1-8. DOI: 10.1007/s11684-020-0754-0. DOI: https://doi.org/10.1007/s11684-020-0754-0

Lai, C. C., Liu, Y. H., Wang, C. Y., Wang, Y. H., Hsueh, S. C., Yen, M. Y., ... & Hsueh, P. R. (2020). Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths. Journal of Microbiology, Immunology and Infection. pii:S1684-1182(20)30040-2. DOI: 10.1016/j.jmii.2020.02.012. DOI: https://doi.org/10.1016/j.jmii.2020.02.012

Li, Z., Huang, Y., & Guo, X. (2020). The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion. Sci. China Life Sci., 63 (5), 771-773. https://doi.org/10.1007/s11427-020-1690-y. DOI: https://doi.org/10.1007/s11427-020-1690-y

Varga, Z., Flammer, A.J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A.S., ... & Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395 (10234), 1417-1418. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5

Kuster, G.M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., ... & Osswald, S. (2020). SARS-CoV-2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? European Heart Journal, 41 (19), 1801-1803. https://doi.org/10.1093/eurheartj/ehaa235. DOI: https://doi.org/10.1093/eurheartj/ehaa235

Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., ... & Zeng, X. (2020). The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China. Clinical Immunology, 108393. DOI: 10.1016/j.clim.2020.108393. DOI: https://doi.org/10.1016/j.clim.2020.108393

Davies, J., Randeva, H.S., Chatha, K., Hall, M., Spandidos, D.A., Karteris, E., & Kyrou, I. (2020). Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Molecular Medicine Reports, 22 (5), 4221-4226. https://doi.org/10.3892/mmr.2020.11510 DOI: https://doi.org/10.3892/mmr.2020.11510

Song, J., & Ruan, Q. (2000). Mechanism of ligustrazini against thrombosis. Chinese Medical Journal, 113 (2), 136. https://doi.org/10.1002/1097-0320(20000801)40:4<271::AID-CYTO3>3.0.CO;2-C. DOI: https://doi.org/10.1002/1097-0320(20000801)40:4<271::AID-CYTO3>3.0.CO;2-C

Ziegler, C.G., Allon, S.J., Nyquist, S.K., Mbano, I.M., Miao, V.N., Tzouanas, C.N., ... & Feldman, J. (2020). SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell, 181 (5),1016-1035. e19. https://doi.org/10.1016/j.cell.2020.04.035. DOI: https://doi.org/10.1016/j.cell.2020.04.035

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395 (10223), 497-506. DOI:10.1016/S0140-6736(20)30183-5. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Lippi, G., & Mattiuzzi, C. (2020). Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematology, Transfusion and Cell Therapy. pii:S2531-1379(20)30029-8. DOI: 10.1016/j.htct.2020.03.001. DOI: https://doi.org/10.1016/j.htct.2020.03.001

Bell, T.J., Zhang, M., Cubillos, P.E., Dang, L., Fossati, L., Todorov, K.O., ... & Crossfield, I.J. (2019). Mass loss from the exoplanet WASP-12b inferred from Spitzer phase curves. Monthly Notices of the Royal Astronomical Society, 489 (2), 1995-2013. https://doi.org/10.1093/mnras/stz2018. DOI: https://doi.org/10.1093/mnras/stz2018

Heldin, P., Lin, C.Y., Kolliopoulos, C., Chen, Y.H., & Skandalis, S.S. (2019). Regulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan production. Matrix Biology, 78, 100-117. https://doi.org/10.1016/j.matbio.2018.01.017. DOI: https://doi.org/10.1016/j.matbio.2018.01.017

Hanff, T.C., Harhay, M.O., Brown, T.S., Cohen, J.B., & Mohareb, A.M. (2020). Is there an association between COVID-19 mortality and the renin-angiotensin system – a call for epidemiologic investigations. Clinical Infectious Diseases, 71 (15), 870-874. https://doi.org/10.1093/cid/ciaa329. DOI: https://doi.org/10.1093/cid/ciaa329

Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A.S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46 (4), 586-590. DOI:10.1007/s00134-020-05985-9. DOI: https://doi.org/10.1007/s00134-020-05985-9

Published

2020-12-04

How to Cite

Maly, V. P., Asoyan, I. M., Sai, I. V., & Andrusovych, I. V. (2020). PATHOGENESIS OF CORONAVIRUS INFECTION COVID-19. Infectious Diseases – Infektsiyni Khvoroby, (3), 73–83. https://doi.org/10.11603/1681-2727.2020.3.11555

Issue

Section

Reviews and lectures